Curaleaf Holdings, Inc.
CURLD CURLFCIK 0001756770 · Medicinal Chemicals & Botanical Products · OTC, OTC
Revenue (TTM)
$1.27B
−5.0% YoY
FY Dec 2025
Net Income (TTM)
−$231.07M
−7.3% YoY
FY Dec 2025
EPS Diluted (TTM)
−$0.35
−9.4% YoY
FY Dec 2025
Gross Margin
49.8%
FY Dec 2025
Operating Margin
2.0%
FY Dec 2025
Net Margin
-18.2%
FY Dec 2025
Free Cash Flow (TTM)
$74.27M
FY Dec 2025
Cash
$163.18M
FY Dec 2025
Total Debt
$548.65M
FY Dec 2025
Shares Outstanding
623.52M sh
FY Dec 2025